Serum levels of IL-19 in PPP patients were found to be significantly higher at baseline when compared to levels in healthy control participants (mean ± standard deviation: 88.8 ± 92.1 pg/ml vs 23.0 ± 37.2 pg/ml, P < .001) (Fig 4, A). This evidence concerns the gene IL19 and palmoplantar pustulosis.